US FDA Drug Center ‘Snapshots’ Show Progress, But Are They Measuring The Right Thing?

diversity hands
Califf wants larger trials to better measure treatment effects in subgroups of interest. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Clinical Trials

More from R&D